BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 10744744)

  • 1. Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation.
    Lewis J; Devin A; Miller A; Lin Y; Rodriguez Y; Neckers L; Liu ZG
    J Biol Chem; 2000 Apr; 275(14):10519-26. PubMed ID: 10744744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement of Hsp90 activity for IkappaB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-kappaB activation.
    Broemer M; Krappmann D; Scheidereit C
    Oncogene; 2004 Jul; 23(31):5378-86. PubMed ID: 15077173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of HSP90 function reverts tumor necrosis factor-induced necrosis to apoptosis.
    Vanden Berghe T; Kalai M; van Loo G; Declercq W; Vandenabeele P
    J Biol Chem; 2003 Feb; 278(8):5622-9. PubMed ID: 12441346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress-induced inhibition of the NF-kappaB signaling pathway results from the insolubilization of the IkappaB kinase complex following its dissociation from heat shock protein 90.
    Pittet JF; Lee H; Pespeni M; O'Mahony A; Roux J; Welch WJ
    J Immunol; 2005 Jan; 174(1):384-94. PubMed ID: 15611262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of NF-kappaB activation by tumor necrosis factor alpha receptor complex-targeted MEKK3 in receptor-interacting protein-deficient cells.
    Blonska M; You Y; Geleziunas R; Lin X
    Mol Cell Biol; 2004 Dec; 24(24):10757-65. PubMed ID: 15572679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat shock protein 90 (Hsp90) regulates the stability of transforming growth factor beta-activated kinase 1 (TAK1) in interleukin-1beta-induced cell signaling.
    Shi L; Zhang Z; Fang S; Xu J; Liu J; Shen J; Fang F; Luo L; Yin Z
    Mol Immunol; 2009 Feb; 46(4):541-50. PubMed ID: 18950863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90.
    Chen G; Cao P; Goeddel DV
    Mol Cell; 2002 Feb; 9(2):401-10. PubMed ID: 11864612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geldanamycin inhibits tyrosine phosphorylation-dependent NF-kappaB activation.
    Crèvecoeur J; Merville MP; Piette J; Gloire G
    Biochem Pharmacol; 2008 Jun; 75(11):2183-91. PubMed ID: 18455150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitization of TRAIL-resistant cells by inhibition of heat shock protein 90 with low-dose geldanamycin.
    Ma Y; Lakshmikanthan V; Lewis RW; Kumar MV
    Mol Cancer Ther; 2006 Jan; 5(1):170-8. PubMed ID: 16432176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of death-inducing signaling complex (DISC) by pro-apoptotic C-terminal fragment of RIP.
    Kim JW; Choi EJ; Joe CO
    Oncogene; 2000 Sep; 19(39):4491-9. PubMed ID: 11002422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN.
    Heyninck K; De Valck D; Vanden Berghe W; Van Criekinge W; Contreras R; Fiers W; Haegeman G; Beyaert R
    J Cell Biol; 1999 Jun; 145(7):1471-82. PubMed ID: 10385526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAK1 is recruited to the tumor necrosis factor-alpha (TNF-alpha) receptor 1 complex in a receptor-interacting protein (RIP)-dependent manner and cooperates with MEKK3 leading to NF-kappaB activation.
    Blonska M; Shambharkar PB; Kobayashi M; Zhang D; Sakurai H; Su B; Lin X
    J Biol Chem; 2005 Dec; 280(52):43056-63. PubMed ID: 16260783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of heat shock protein 90 inhibitor 17-dimethylamino-ethylaminogeldanamycin on TNfalpha-mediated apoptosis and TNF-induced NF-kappaB activation].
    Zhong YJ; Wang X; Zheng XL; Yan YY; Liu XM; Liao LC
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 May; 42(3):303-7. PubMed ID: 21826987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells.
    He KL; Ting AT
    Mol Cell Biol; 2002 Sep; 22(17):6034-45. PubMed ID: 12167698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling.
    Kreuz S; Siegmund D; Scheurich P; Wajant H
    Mol Cell Biol; 2001 Jun; 21(12):3964-73. PubMed ID: 11359904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase.
    Lin Y; Devin A; Cook A; Keane MM; Kelliher M; Lipkowitz S; Liu ZG
    Mol Cell Biol; 2000 Sep; 20(18):6638-45. PubMed ID: 10958661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-induced nuclear factor kappaB activation is impaired in focal adhesion kinase-deficient fibroblasts.
    Funakoshi-Tago M; Sonoda Y; Tanaka S; Hashimoto K; Tago K; Tominaga S; Kasahara T
    J Biol Chem; 2003 Aug; 278(31):29359-65. PubMed ID: 12748169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel zinc finger protein interacts with receptor-interacting protein (RIP) and inhibits tumor necrosis factor (TNF)- and IL1-induced NF-kappa B activation.
    Chen D; Li X; Zhai Z; Shu HB
    J Biol Chem; 2002 May; 277(18):15985-91. PubMed ID: 11854271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 17-allylamino-17-demethoxygeldanamycin synergistically potentiates tumor necrosis factor-induced lung cancer cell death by blocking the nuclear factor-kappaB pathway.
    Wang X; Ju W; Renouard J; Aden J; Belinsky SA; Lin Y
    Cancer Res; 2006 Jan; 66(2):1089-95. PubMed ID: 16424045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stat1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-kappaB activation.
    Wang Y; Wu TR; Cai S; Welte T; Chin YE
    Mol Cell Biol; 2000 Jul; 20(13):4505-12. PubMed ID: 10848577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.